Table 2. Pretreatment clinical characteristics of the 56 study patients.

		EOD
	Total	Grade 1	Grade 2	Grade 3	Grade 4
No. of patient's	56	15	22	15	4
Patient's age (years)
Mean/median	72/72	72/74	72/72	71/71	70/71
Range	49–93	53–93	59–88	49–88	65–75
EOCG performance status
0+1	41	12	18	10	1
2+3	15	3	4	5	3
Biopsy grade
Well differentiated	7	4	1	2	0
Moderately differentiated	27	9	10	7	1
Poorly differentiated	22	2	11	6	3
PSA (ngml−1)
Mean/median	425/220	144/112	321/171	517/296	1713/2000
Range	2–2000	14–561	2–1755	19–1967	853–2000
Alkaline phosphatase (IUl−1)
Mean/median	635/467	343/233	499/357	1001/718	1101/774
Range	91–4751	118–1079	194–2334	91–4751	659–2197
ICTP (ngml−1)
Mean/median	8.5/6.1	5.1/4.5	7.1/5.9	11.9/6.6	16.9/17.1
Range	1.9–52	2.5–8.5	1.9–26.5	4.3–52	11.2–22.2
No of bone lesions
Mean/median	23/14	4/4	13/12	38/30	100/100
Range	1–100	1–5	6–20	21–80	100–100
PABS (%)
Mean/median	7.7/4.6	1.6/0.9	4.0/3.6	14.1/12.8	26.7/23.3
Range	0.2–43.3	0.2–5.9	1.5–9.7	501–27.6	17.1–43.3